The Combination Chemotherapy of SIRIOX as First- or Second-Line Chemotherapy for Pancreatic Cancer

Clinical trial NCT03403101 · UNKNOWN

Trial details

NCT number: NCT03403101
Sponsor: Fudan University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Pancreatic Ductal

Start date: 2020-07-01
Primary completion: 2023-12-31
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.